Impact Assessment and Risk Management for Change Control

18 Nov 2024
10:00 AM PDT | 01:00 PM EDT
60 Minutes
In this webinar, we will examine the process of evaluating and completing an impact assessment when applied to change control. We will discuss how to determine the level of impact assessment needed for what type of changes and how to base this decision on risk. A major part of the discussion will be the development of tools that can be used to do a complete impact assessment and how this will lead to a change plan to complete any activities needed to fully verify/validate the change. We will also be discussing a tool for doing a change-specific risk assessment which highlights the risks associated with the change. Applicable regulatory guidance will also be discussed.

WHY SHOULD YOU ATTEND?

Control of changes is critical in a regulated industry such as pharma or medical devices. Improper, incomplete, or missing impact assessments of changes can lead to the production of a product which is unfit for market or the inability to produce good product at all. By controlling changes and doing a proper assessment of the impact of the change, including a complete risk analysis, undesirable effects of changes can be avoided.

LEARNING OBJECTIVES

  • Change and the drivers of change
  • Regulatory guidance or lack of guidance
  • Elements of a change description
  • Classification of changes: Minor changes and Everything else
  • Change impact assessments
  • Justification for why the change can be made
  • Strategies for doing complete impact assessments

WHO WILL BENEFIT?

  • Professionals in quality assurance, regulatory affairs, technical, R&D, and manufacturing working in the pharma or medical device industries.
Control of changes is critical in a regulated industry such as pharma or medical devices. Improper, incomplete, or missing impact assessments of changes can lead to the production of a product which is unfit for market or the inability to produce good product at all. By controlling changes and doing a proper assessment of the impact of the change, including a complete risk analysis, undesirable effects of changes can be avoided.
  • Change and the drivers of change
  • Regulatory guidance or lack of guidance
  • Elements of a change description
  • Classification of changes: Minor changes and Everything else
  • Change impact assessments
  • Justification for why the change can be made
  • Strategies for doing complete impact assessments
  • Professionals in quality assurance, regulatory affairs, technical, R&D, and manufacturing working in the pharma or medical device industries.
Currency:
Webinar Option
Live + Recorded Session
Live + Transcript
Live + USB
Transcript (PDF Transcript of the Training)
Downloadable Recorded Session
USB
Group Session Participants + Recorded

Live Session with unlimited participants. Invite any number of attendees to join.

Speaker Profile

ins_img Alan M Golden

Alan M Golden has over 30 years of experience in the medical device industry, both in basic research and quality assurance. Alan spent 31 years at Abbott Laboratories. For the first 16 years as part of diagnostics R&D, he developed recombinant proteins used in diagnostics tests, received three US patents, and published numerous papers and abstracts. Alan then transitioned to a quality assurance role wherein both the Abbott Diagnostics and Abbott Molecular divisions, he was responsible for quality assurance for new product development, on-market product support, and operations.Alan’s quality assurance experience extends from design control, change control, risk …

Upcoming Webinars